Editorial: Frontiers in Autoimmune Disease: Rheumatic Fever and Rheumatic Heart Disease by Luiza Guilherme et al.
October 2015 | Volume 3 | Article 911
Editorial
published: 28 October 2015
doi: 10.3389/fped.2015.00091
Frontiers in Pediatrics | www.frontiersin.org
Edited by: 
Oswin Grollmuss, 
Centre Chirurgical Marie 
Lannelongue, France
Reviewed by: 
Teresa M. Coque, 
Hospital Universitario Ramón y Cajal, 
Spain
*Correspondence:
Luiza Guilherme 
luizagui@usp.br
Specialty section: 
This article was submitted to 
Pediatric Cardiology, a section of the 
journal Frontiers in Pediatrics
Received: 08 May 2015
Accepted: 14 October 2015
Published: 28 October 2015
Citation: 
Guilherme L, Köhler KF and Faé KC 
(2015) Editorial: Frontiers in 
autoimmune disease: rheumatic fever 
and rheumatic heart disease. 
Front. Pediatr. 3:91. 
doi: 10.3389/fped.2015.00091
Editorial: Frontiers in autoimmune 
disease: rheumatic fever and 
rheumatic heart disease
Luiza Guilherme* , Karen F. Köhler and Kellen C. Faé
Laboratory of Immunology, Heart Institute (InCor), School of Medicine, University of São Paulo, São Paulo, Brazil
Keywords: rheumatic fever, rheumatic heart disease, autoimmune diseases, valvular damage, innate and adaptive 
immune response, animal model
Rheumatic fever (RF) and rheumatic heart disease (RHD), its most clinically consequence, resulting 
from untreated throat Streptococcus pyogenes infection in susceptible children, are considered as 
models of autoimmune post-infectious disease. This Research Topic compiled clinical and scientific 
data and brings interesting viewpoints of clinicians and basic researchers. The ensemble of data and 
ideas certainly makes a new portrait of the mechanisms leading the autoimmune reactions. On the 
other hand, the clinical data contributes with the diagnosis and prevention of the disease.
Rheumatic fever and RHD are still prevalent in diverse regions of the world (1–3). The correct 
diagnosis is very important as well as the clinical treatment.
Briefly, in Brazil, both RF and RHD are still important diseases in different regions (4). A RF 
prevention program involving more than 700 children with RF/RHD was performed. This program 
evaluated the long-term evolution and outcomes after the control of recurrences. These data are 
presented and discussed by Mota et al. (5). Another interesting article, done by Spina et al., discusses 
the clinical diagnosis of acute rheumatic myocarditis in asymptomatic RHD patients (6).
As RF and RHD are autoimmune diseases, the mechanisms leading to autoimmune reactions 
involve several molecules that play a role in the immune response against the bacteria (7, 8). As 
we know, protective response involves several molecules that are genetically controlled, from both 
innate and adaptive immune response, in order to eradicate an infection (8). Among these molecules, 
complement plays an important role in the immune response against S. pyogenes. The lectin pathway 
of complement and RHD is discussed by the group de Messias-Reason (9).
Another interesting article on autoimmune targets is presented by Root-Bernstein. In his article, 
a parallel between molecular mimicry reactions on RHD and autoimmune myocarditis is estab-
lished (10).
Rheumatic fever and RHD are considered as prototypes of human autoimmune diseases, and 
no animal models could reproduce accurately the disease. In the past few years, however, experi-
ments on Lewis rat showed some similar autoimmune reactions in the myocardium of S. pyogenes 
immunized mice. The article by the group of Ketheesan presented a historical overview of animal 
models that were used to investigate the pathogenesis of RF/RHD (11).
I hope the readers enjoy this collection, and I and my co-editors are grateful of having the 
 opportunity to prepare this Research Topic for Frontiers in Pediatrics.
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